Kayleigh C. Ross

Identification of the Serine Biosynthesis Pathway as a Critical Component of BRAF Inhibitor Resistance of Melanoma, Pancreatic, and Non–Small Cell Lung Cancer Cells

Kayleigh C. Ross, Andrew J. Andrews, Christopher D. Marion et al. · Molecular Cancer Therapeutics · 2017 · 113 citations · Full text

Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models

Stefano Pierini, Rashid Gabbasov, Maria Cecília Oliveira-Nunes et al. · Nature Communications · 2025 · 60 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Immunology +8

Methotrexate sensitizes drug-resistant metastatic melanoma cells to <i>BRAF</i> V600E inhibitors dabrafenib and encorafenib

Kayleigh C. Ross, Kevin F. Chin, Dae‐Hwan Kim et al. · Oncotarget · 2018 · 30 citations · Full text

Abstract 1530: Anti-HER2 CAR monocytes demonstrate targeted anti-tumor activity and enable a single day cell manufacturing process

Linara Gabitova, Brett Menchel, Rashid Gabbasov et al. · Cancer Research · 2021 · 11 citations

128 Development of an M1-polarized, non-viral chimeric antigen receptor macrophage (CAR-M) platform for cancer immunotherapy

Yumi Ohtani, Kayleigh C. Ross, Aditya Dandekar et al. · Regular and Young Investigator Award Abstracts · 2020 · 10 citations · Full text